BTMD (Biote Corp. Class A Common Stock) Stock Analysis - Insider Trades
Biote Corp. Class A Common Stock (BTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, BTMD trades at $2.10 with a market cap of $57.93M and a P/E ratio of 4.28. BTMD moved +6.08% today. Year to date, BTMD is -14.98%; over the trailing twelve months it is -47.24%. Its 52-week range spans $1.27 to $6.98. Analyst consensus is strong buy with an average price target of $2.50. Rallies surfaces BTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Does Rallies show Form 4 insider transactions for BTMD?
Yes. Rallies tracks BTMD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BTMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BTMD. It does not provide personalized investment advice.